APPLICATION
ANDA070092
TYPE
ANDA
ORIGINAL APPROVAL
1985-10-23
LATEST ACTION
2002-07-17
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
DOPAMINE HYDROCHLORIDEDiscontinued
DOPAMINE HYDROCHLORIDE 160MG/ML · INJECTABLE · INJECTION
Approval history
2002-07-17Labeling · Supplement 11AP
1996-10-03Labeling · Supplement 10AP
1992-06-02Labeling · Supplement 9AP
1991-09-30Manufacturing (CMC) · Supplement 7AP
1991-09-30Manufacturing (CMC) · Supplement 8AP
1988-08-03Manufacturing (CMC) · Supplement 5AP
1988-08-03Manufacturing (CMC) · Supplement 6AP
1987-03-31Manufacturing (CMC) · Supplement 3AP
1985-10-23OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.